- Home
- Equipment
- netherlands
- cervical cancer
Show results for
Refine by
Cervical Cancer Equipment Supplied In Netherlands
6 equipment items found
by:CC Diagnostics based inGroningen, NETHERLANDS
During their fundamental research in the last 15 years, this group has identified and clinically-validated numerous CIN2+-specific tumor-suppressor genes deregulated by DNA hypermethylation. They reported that DNA methylation status of these genes has predictive value whether or not cervical cancer or its precursors are present in cervical ...
Manufactured by:Self-screen B.V. based inAmsterdam, NETHERLANDS
Precursor-M Gold demonstrates very good clinical performance in the detection of high grade precursor stadia and cervical cancer among HPV positive women. The assay is ready for further IVD validation on a platform or workflow of choice. ...
Manufactured by:Self-screen B.V. based inAmsterdam, NETHERLANDS
The QIAsure Methylation Test is a multiplex real-time methylation specific PCR-based (qMSP) assay that detects hyper methylation of 2 disease related marker genes, FAM19A4 and mir124-2, to distinguish women with cervical (pre)cancer. The test specifically detects women with a cancer-like methylation profile, which are indicative for the women who ...
Manufactured by:Lightpoint Medical, Ltd based inWaterside, UNITED KINGDOM
Designed for radio-guided surgical procedures, the sterile, disposable SENSEI® probe quickly expands the field of view and enables the localization of radioactive hotpots in multiple ...
Manufactured by:Lightpoint Medical, Ltd based inWaterside, UNITED KINGDOM
Using next-generation miniaturized sensor technology, the SENSEI probe measures just over 40mm in length, enabling unprecedented intracavity maneuverability and anatomic access for surgical ...
Manufactured by:ViciniVax BV based inGroningen, NETHERLANDS
Our first product candidate Vvax001, a therapeutic cancer vaccine against (pre)malignant cervical lesions, is currently in clinical development. We outsource process development and GMP manufacturing to experienced CMO’s, leading to a first clinical trial, which has been started in ...